...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Data Expected September 2019 for BETonMACE Phase 3 Cardiovascular Outcomes Trial for Apabetalone

Message: $2.77 with a new 52 week high.....

And it looks to me like there's still plenty of upside left, would love to see a run at $3 CDN...

New Message
Please login to post a reply